Supply of Gentamicin Sulfate Injection (NSN 6505012139514)

The contract obligates the contractor to manufacture, package, and deliver exactly 2,000 units of sterile Gentamicin Sulfate Injection identified by NSN 6505012139514, ensuring full compliance with federal pharmaceutical standards and Department of Defense logistics protocols. The product must meet rigorous quality, sterility, and labeling requirements to support military medical readiness, with all units destined for DoD use under the supervision of the Defense Logistics Agency. The work is conducted under a subcontract mechanism, classified under NAICS code 325412 for pharmaceutical and biological product manufacturing, with performance requirements aligned to the stringent standards expected by the Department of Defense. The contract was posted on August 9, 2026, and is referenced under the award number SPE2DX25D8022 with delivery order SPE2D926F8060, indicating it is part of a broader procurement effort managed by the DLA. No specific set-aside provisions or small business designations are indicated, and while the exact place of performance is unspecified, all manufacturing and packaging must occur in facilities meeting federal cGMP guidelines. The delivery timeline and packaging specifications are governed by DoD supply chain protocols, and the contractor is responsible for end-to-end traceability, documentation, and compliance to ensure seamless integration into military medical inventory systems.